Bedel Financial Consulting’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-24
Closed -$6K 473
2022
Q1
$6K Hold
24
﹤0.01% 744
2021
Q4
$6K Hold
24
﹤0.01% 750
2021
Q3
$6K Hold
24
﹤0.01% 749
2021
Q2
$5K Hold
24
﹤0.01% 769
2021
Q1
$5K Hold
24
﹤0.01% 743
2020
Q4
$4K Hold
24
﹤0.01% 680
2020
Q3
$3K Hold
24
﹤0.01% 674
2020
Q2
$2K Hold
24
﹤0.01% 685
2020
Q1
$2K Hold
24
﹤0.01% 674
2019
Q4
$4K Buy
+24
New +$3.22K ﹤0.01% 609

Other funds holding HCA

Bedel Financial Consulting's HCA Position: Q2 2022 in Review

Bedel Financial Consulting sold out of HCA Healthcare (HCA) in Q2 2022, closing a stake of 24 shares — an estimated $6K sold.

Bedel Financial Consulting first reported a position in HCA in Q4 2019 and held it in 10 quarters. The position peaked at $6K in Q1 2022. 883 funds tracked by Wall St. Rank hold HCA as of Q2 2022.

  • Bedel Financial Consulting reported no remaining HCA Healthcare position as of Q2 2022 after selling out during the quarter.
  • Bedel Financial Consulting sold 24 HCA Healthcare shares in Q2 2022, an estimated $6K.
  • Bedel Financial Consulting first reported a position in HCA Healthcare in Q4 2019 and held it in 10 quarters.
  • Bedel Financial Consulting's HCA Healthcare position peaked at $6K in Q1 2022.
  • 883 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2022.

Based on Bedel Financial Consulting's 13F filing for Q2 2022, filed 4 Aug 2022.